Abstract:

Tumor immunotherapy is a new therapy to inhibit and kill tumor by restarting and maintaining the immune function damaged in the process of tumor occurrence and development,with the advantages of small adverse reaction, high specificity, wide killing spectrum and low recurrence rate. Endometrial cancer is one of the most common malignant tumors in female reproductive system, and the incidence rate is on the rise and tends to be younger. It is a serious threat to the health of women. At present, many tumor immunotherapies have been used in clinical practice or clinical trial of endometrial cancer, including immunosuppressive checkpoint inhibitors, adoptive T cell therapy (ACT) and tumor vaccine, with the great progress. However, its clinical application is still hindered by the low response rate and drug resistance. It is of great significance to find more efficient tumor immunotherapy for the treatment of endometrial cancer. This article reviews the research progress of tumor immunotherapy in endometrial cancer, in order to provide new ideas for the treatment of endometrial cancer.

Key words: Immunotherapy, Neoplasms, Endometrial neoplasms, Therapy, Vaccines